The Committee to Restore Nymox Shareholder Value Reminds All Nymox Pharmaceutical Shareholders to Ta
Condemns Nymox’s Dissemination of False and Misleading Information Regarding CRNSV, its Nominees and the Special Meeting and Believes Such Actions Underscore the Dire Need for New Leadership and a New Board at NymoxBelieve Shareholders Will See Through CEO Averback’s & the Board’s Desperate and Unprofessional Attemp...
Source: pharmiweb.com